High seroprevalence but low incidence of HCV infection in a cohort of patients with sexually transmitted HIV in Andalusia, Spain

J Int Assoc Physicians AIDS Care (Chic). 2009 Mar-Apr;8(2):100-5. doi: 10.1177/1545109709331474. Epub 2009 Feb 11.

Abstract

Purpose: To analyze the prevalence and the incidence of hepatitis C virus (HCV) seropositivity in sexually transmitted human immunodeficiency virus (HIV) patients.

Methods: Observational study of 1468 sexually transmitted HIV-infected patients from 7 hospitals (Southern Spain). Characteristics of HCV cases, and incidence of HCV seroconversion was assessed.

Results: Seroprevalence of HCV was 16.1%, higher among heterosexual than homosexual patients, and similar between heterosexual men and women. Seroincidence was 0.16 cases per 100 patient-years, similar between homosexual and heterosexual patients. HCV patients had a mean CD4 of 523 cells/microl, 82.0% were on highly active antiretroviral therapy (HAART), and 72.0% had undetectable HIV viral load. Serum HCV-RNA was positive in 79.0% cases, and only 16.0% had ever received HCV treatment.

Conclusions: HCV seroprevalence among sexually transmitted HIV-infected patients is more frequent than in the general population; however, incidence of HCV infection is currently low. Patients with sexually transmitted HIV coinfected with HCV have their HIV infection well controlled, but HCV infection was treated in few cases.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Cohort Studies
  • Female
  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • HIV Infections* / transmission
  • HIV Infections* / virology
  • HIV-1
  • Hepacivirus / immunology*
  • Hepacivirus / isolation & purification
  • Hepatitis C / epidemiology*
  • Hepatitis C / immunology
  • Hepatitis C / virology
  • Hepatitis C Antibodies / blood*
  • Heterosexuality
  • Homosexuality
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prevalence
  • Seroepidemiologic Studies
  • Sexual Behavior
  • Sexually Transmitted Diseases, Viral* / complications
  • Sexually Transmitted Diseases, Viral* / transmission
  • Sexually Transmitted Diseases, Viral* / virology
  • Spain / epidemiology

Substances

  • Hepatitis C Antibodies